article · Viruses
The abstract on record is too brief for a reliable plain-language summary, so none has been generated.
Recently, a <i>Salmonella</i> Typhi isolate producing CTX-M-15 extended spectrum β-lactamase (ESBL) and with decreased ciprofloxacin susceptibility was isolated in the Democratic Republic of the Congo. We have selected bacteriophages that show strong lytic activity against this isolate and have potential for phage-based treatment of <i>S</i>. Typhi, and <i>Salmonella</i> in general.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3390/v10040172
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.